The FDA has issued a Complete Response Letter for Donanemab, a potential treatment for Alzheimer's disease. The Alzheimer's Association provides resources and support for individuals with Alzheimer's and their caregivers, covering topics such as diagnosis, treatments, legal and financial planning, caregiving, safety, and research. The organization also offers educational programs, virtual events, an online community for support, and promotes brain health. The Alzheimer's Association is committed to research and progress in the diagnosis and treatment of Alzheimer's disease, offering clinical trials, funding opportunities, partnerships, and advocacy programs. The organization also provides resources for those looking to donate or volunteer, and offers support for people living with dementia and their families.